{"nct_id":"NCT00823979","title":"A Phase 2B Multicenter, Randomized, Comparative Trial Of UK-453,061 Versus Etravirine In Combination With Darunavir/Ritonavir And A Nucleos(t)Ide Reverse Transcriptase Inhibitor For The Treatment Of Antiretroviral Experienced HIV-1 Infected Subjects With Evidence Of NNRTI Resistant HIV-1","status":"TERMINATED","status_verified_date":"2018-11","start_date":"2009-03-25","start_date_type":"ACTUAL","primary_completion_date":"2012-10-18","primary_completion_date_type":"ACTUAL","completion_date":"2012-10-18","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["PFE"]}